Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Pfizer
Pfizer
Mirati Therapeutics Inc.
Eli Lilly and Company
Canadian Cancer Trials Group
Astellas Pharma Inc
Genentech, Inc.
National Cancer Institute (NCI)
Janssen Research & Development, LLC